Tonix Publishes Mpox Study Supporting TNX-801 Vaccine
BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...
COPENHAGEN, DENMARK — February 18, 2026 Bavarian Nordic has secured a USD 22.5 million vaccine supply contract from the...
